Polyphor and Axxam agree discovery and development collaboration
This article was originally published in Scrip
Executive Summary
Polyphor and Axxam have agreed to collaborate in the discovery and development of therapies in the fields of pain, inflammation and metabolic disorders. Axxam will combine its hit discovery platforms with Polyphor's proprietary PEMfinder library for discovery programmes in ion channel-based targets.